• Strategic planning based off of 125 years of combined experience in the beverage industry
• Significant expected growth in the beverage and cannabis industry as the two join forces
• Multi-phase product to create a distribution platform for domestic and international markets
• Creating a sustainable and successful future that provides quality product worldwide

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a company that produces farm-grown, high quality organic medical cannabis using organic craft growing principles, has announced a global strategic launch into the beverage industry.  The company’s senior management has over 125 years of combined experience in the beverage industry, with international soft drink and beverage alcohol companies in Canada and the United States. They plan to put this experience to work in creating a strategic path into the cannabis beverage market (http://ibn.fm/KdcaL).

Currently, the global beverage industry represents over $1 trillion in sales, according to industry-leading research firm Brightfield Group, and the hemp and CBD category is expected to reach $1 billion by 2020 in the United States. With the beverage industry already accounting for 11 percent of the edible market, the expansion into cannabinoid-infused beverages, such as CBD iced teas, juices and sports drinks, is expected to significantly grow the industry. The company plans to create unique, healthy, organic products for the recreational and medicinal markets while utilizing its expertise through direct investment, joint venture and other strategically suitable opportunities to meet this growing demand. TGOD’s global strategy is twofold. The company will create industry-leading branded products and supply global beverage brands with organic base ingredients. To meet demand and increase product offerings in anticipation of Canada’s legalization of sales to recreational users, TGOD expects to bring its total cannabis production levels to 116,000 kg.

The company is currently developing a 40,000-square-foot state-of-the-art research and development space that includes product development and pilot manufacturing for the beverage industry. This facility is part of a multiple phase project that will foster a first-of-its-kind collaborative environment for joint ventures and partnerships and will become a distribution platform for domestic and international markets in the cannabinoid infused beverage industry. This is part of a multi-phased project located on a 72-acre property in Salaberry-de-Valleyfield, Quebec. The Valleyfield property will feature hybrid facilities with state-of-the-art climate-controlled environment paired with cutting edge automatization technology, including separate zones with independent air handling and environmental systems providing TGOD with optimal growing conditions to produce consistent, high quality organic and pesticide-free cannabis.

TGOD is unique in its approach to the industry. By growing organically (one of only three out of 100+ growers in Canada that does so) and at low costs, the company is creating a product that demands a premium in the market. TGOD has an alliance partnership with Eaton Corp., the second largest power management company in the world that is striving to become a leader in cannabis growing power management and lighting and is doing so by providing TGOD with research and optimization. Through the combined partnerships with Eaton and Ledcor, and operating in power-conscious jurisdictions, the company is positioned to be one of the lowest cost producers in the country. Through strategic partnerships and planning, TGOD is focused on creating a sustainable and successful future that provides quality product worldwide.

For more information, visit the company’s website at www.TGOD.ca

• Sunniva’s Sun-Oil Facility in California will provide Farmacy Phactory with distilled oil products
• Extraction deal is a significant milestone for the company, cements its position as a reliable manufacturer of clean extracted products
• New clinic opened in Windsor, Ontario, via wholly owned subsidiary Natural Health Services

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis provider, has struck an extraction deal with Farmacy Phactory, a family-run California cannabis farm (http://ibn.fm/6ZyUd). Through wholly owned subsidiary CP Logistics, LLC, Sunniva’s Sun-Oil Facility will provide high quality, pure manufactured distilled oil products, including flavored oil formulations for vaporization cartridges. Sunniva will also sell specialized vaporization equipment for use in the therapeutic delivery of the products.

The contract was signed for an initial 12-month term and may be renewed for a further 12 months if Farmacy Phactory elects to do so. Farmacy Phactory is a leading producer of unique high-terpene strains of cannabis, and it is making a name for itself with high-quality products. It combines organic methods with proven traditional techniques to produce a range of exotic strains (http://ibn.fm/w9mhD).

“This is a significant milestone as it establishes Sunniva as a trusted manufacturer of clean, high quality extracted products and reliable hardware to support the vibrant California extraction market place,” Sunniva CEO Dr. Anthony Holler stated in a news release. He explained that the Sun-Oil Facility, which is located one mile from the company’s California Campus in Cathedral City, has a capacity to produce more than 600,000 filled vaporization cartridges a month. The facility is licensed for both volatile and non-volatile extraction, which will allow Sunniva to manufacture different extracted products. The company also has plans to sign more white label contracts with other leading brands in the Golden State, Holler further explained.

“We are pleased to partner with Sunniva to access their manufacturing and product expertise. This agreement is a validation of their large-scale extraction operations and we are excited to bring new products to the California marketplace,” added Mark Greene, president of Farmacy Phactory.

Meanwhile, in Canada, Sunniva’s wholly owned subsidiary, Natural Health Services Ltd., the country’s largest referral network of clinics and trained health professionals, invited members of the public and the press for an open house at its Windsor, Ontario, clinic (http://ibn.fm/yzLjk).

At the clinic’s grand opening celebration on May 30, regional manager Lisa Hogan said that this was the culmination of a long journey and that NHS was excited to be able to provide an important service for the local community (http://ibn.fm/rfcNh).

Speaking to Chris Foord, the host of the Cannabis Show (http://ibn.fm/aPaVl), Hogan said, “We’re going to be focusing on an education-based model of care for our patients that focuses on safe access to medical cannabis: proper education, providing them with the insights of if it’s even a proper product for them, how it can help them, and then, of course, product matching and LP matching and connecting them to those services that will meet their needs.”

The clinic, which is free for patients at the point of use, is now open to take bookings.

With some experts estimating that up to 90 percent of California’s cannabis extracts may be tainted with pesticides, Sunniva’s main goal is to provide safe, cost-effective products. The company operates in the largest cannabis markets in the world – California and Canada, and it aims to become the lowest cost, highest quality cannabis manufacturer in these two markets by providing products that are free of pesticides and building large-scale greenhouses that are compliant with current Good Manufacturing Practices. Through this commitment to detail, Sunniva aims to enable better doctor and patient access to cannabis education and facilitate improved delivery devices for therapeutic purposes.

For more information, visit the company’s website at www.sunniva.com

• Quebec grant will help develop its cannabinoid products; ETST testing will commence in 4Q2018 on formula patents aimed at preventing cancer and other diseases
• ETST will apply for trademark, finalize packaging for debut of medical device designed to diminish sexually transmitted infections; women will be target audience for this product
• Company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol

Earth Science Tech, Inc. (OTC: ETST) has established testing dates for three of its cannabinoid-based (CBD) products. Funded by a grant from Quebec, ETST is now prototyping three CBD patent formulas. A superfood edible is expected to be ready for 4Q2018. The company is scheduled to begin in vitro testing on its first batch of formulas in the summer of 2019, with a goal of demonstrating the superior antioxidant properties and anti-proliferative effects on breast cancer cells, it announced (http://ibn.fm/egQlU).

The goal of these products is to stop inflammation, maintain quality of life, and help prevent cancer and other degenerative diseases. The branding of these three products is in the planning stage.

ETST, a biotech company based in Doral, Florida, has repositioned its line of full-spectrum CBD offerings. It also conducts R&D for low cost, non-invasive medical devices as it concentrates on manufacturing, marketing and distributing its cannabinoid products to the nutraceutical and pharmaceutical markets.

Its MSN-2 medical device is in its final stage prior to the launch of large-scale marketing. ETST is working with Montreal-based Acceleration, Design et Innovation Inc. to aid in the preparation and introduction. Final packaging is being designed to appeal to its target global audience of women. The device is developed to prevent chlamydia and other sexually transmitted infections.

“The official launch of this medical device is a little like giving birth,” Dr. Michel Aube, CEO and chief science officer of ETST, stated in a news release. “It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name.”

ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit, accepting grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also has subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company formed to provide ETST with access to government grants.

For more information, visit the company’s website at www.EarthScienceTech.com

• Universal Mobile Interface™ integrates any stream of data onto mobile devices
• CSRH’s first predictive data analytics mobile offering targets 2.5 billion cricket fans
• Supreme Court ruling to benefit growing online gaming market

As a mobile solutions and software development company, Consorteum Holdings, Inc. (OTC: CSRH) is focused on mobile device digital offerings delivery. Consorteum further provides mobile payment solutions and products through its mix of direct offerings, license agreements and joint business agreements. Following a multi-year transition, the company has moved from transaction management with a focus on processing solutions and payment processing alongside financial transaction markets to one that focuses on deepening the company’s commitment to delivering innovative solutions via multiple business verticals (http://ibn.fm/jNNhX).

With its focused efforts on software development and delivery solutions to mobile devices, CSRH enhances delivery of mobile content and mobile payment solutions. With many mobile applications limited by how users are able to interact or by the number of supported devices, CSRH’s key product, its Universal Mobile Interface™ (UMI), provides a state-of-the-art platform that has been designed to integrate any stream of data onto mobile devices, regardless of the operating system. The UMI platform aims to strengthen business verticals with particular focus on fintech management, digital marketing, data storage, cloud utilization, analytics, customer relations management and secure payment processing while providing compliance with regulatory codes (http://ibn.fm/NUNB9).

The company’s UMI technology supports fully regulated, regionally compliant financial and social transactions via mobile and web, enabling the development of a cross operating system to support all mobile devices while satisfying the complex and highly regulated requirements of the mobile fintech sector. The world is on the cusp of a digital communication revolution, and CSRH has strategically positioned itself to help clients bridge the mobile and online divide. Its flagship product, the UMI solution, opens-up opportunities in multiple business verticals in multiple sectors of data analytics, next-gen banking, CRM services, social media, digital marketing and e-commerce. The platform takes care of both the API and the UI aspects of mobile software development, which makes the company’s services truly comprehensive. The UMI solution is extremely flexible, and it can easily be adapted to suit the individual needs of clients. 359 Mobile Inc. has further plans to develop and deploy end-to-end solutions for both cloud and host-based products in the fintech and data analytics industries (http://ibn.fm/DSYwf).

A joint development and distribution agreement between Consorteum Holdings, Inc. and DevLex Ltd. provided the framework for the upcoming release of CSRH’s first predictive data analytics mobile offering with specific focus on the game of cricket, a sport with 2.5 billion fans worldwide (http://ibn.fm/aCVoL). This marked an important milestone in the company’s progress, with the CEO of Consorteum, Craig Fielding, noting in a news release, “An extraordinary amount of work by a dedicated team has gone into not only the technological building of our Predictive Analytics platform, but also into the creation and continual update of the massive statistical database required to support this innovative tool.” Being released by CSRH’s wholly owned subsidiary, 359 Mobile Inc., the company makes further use of its UMI technology for the worldwide distribution of the Predictive Analytics Platform (http://ibn.fm/lA05i).

This cutting-edge predictive analytics tool provides cricket fans with real-time and predictive analytics for deployment to mobile devices with the intent of offering its platform for other sports in the future. A recent article indicates that the move is not only a game-changer for cricket enthusiasts, but the first of many financial technology endeavours for CSRH to capitalize on its fintech focus. This innovative tool requires continual update of a massive statistical database that will soon be in the hands of global cricket fans. A primary target of the UMI platform was to closely work with the interests of sport enthusiast activities online and, subsequently, its mobile gaming industry. With a growing market for online gaming that is predicted to surpass the $1 trillion mark by 2022 (http://ibn.fm/w6yj1), entering the gaming sector strategically positions CSRH for continued growth (http://ibn.fm/lUajX).

A ruling by the Supreme Court on May 14 of this year delivered a states’ rights victory to advocates of sports betting (http://ibn.fm/z7uKK), also notching up wins for companies that have maintained multi-jurisdictional presences for online sports wagers, as well as the companies that supply them with the tech, oversight and marketing services they need to operate (http://ibn.fm/JwP12).

It is with this information in mind that Consorteum aims to promote its state-of-the-art UMI platform that easily lends itself to the delivery of mobile content, along with its suite of mobile offerings and payment solutions.

For more information, visit the company’s website at www.Consorteum.com

• Advanced Driver Assistance Systems (ADAS) market to reach $143 billion by 2025
• Successful test of Eye-Net V2X (vehicle to everything) cellular-based accident prevention system
• Analyst coverage recently initiated

What could be smarter than playing it safe, particularly when on the road as a driver? Driving defensively certainly helps, but, more often than expected, the unexpected happens. If only you could have had some inkling of what was coming. Well perhaps you can. Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) is developing unique safety solutions for the automotive industry that provide real-time information to prevent accidents. Combining stereo/quad-camera vision with three-dimensional (3D) video analysis, advanced algorithms and sensor fusion, FRSX’s safety systems will make every car a safer car. Already incorporated into two flagship products, Eyes-On and QuadSight, the company recently completed the successful trial of a third, Eye-Net. FRSX’s groundbreaking work is now garnering attention, with JGR Capital, an independent equity research firm, announcing initiation of coverage (http://ibn.fm/Cqzni).

Just as they have enhanced our mobile phones, rapidly developing advances in information technology are making cars smarter. Smart cars save on fuel costs, provide more creature comforts and help us navigate, but none of that matters if there is danger in driving, which is why most ADAS are putting safety first. Driven in part by government safety regulations and higher consumer expectations, the global ADAS market is projected to ‘reach $143 billion by 2025’, according to a report cited by Body Shop Business (http://ibn.fm/GATHS). With its potentially lifesaving products, FRSX is likely to be part of that developing market.

Presently, FRSX is able to offer three accident prevention products: Eyes-On, QuadSight and Eye-Net. The Eyes-On ADAS System is a stereo vision ADAS system supplemented by advanced algorithms that perform accurate depth analysis and detect all obstacles. The system scans the road for vehicles, animals, cyclists, pedestrians and other possible obstacles, providing accurate and reliable object detection while ensuring the lowest rates of false alerts. It detects much smaller objects than comparable systems on the market and has the capability to detect at long-range and at very high speeds.

The QuadSight System is a four-camera multi-spectral vision system targeting the semi-autonomous and autonomous vehicle market. It employs two sets of stereoscopic infrared and visible-light cameras, enabling highly accurate and reliable obstacle detection. The QuadSight System aims to achieve near 100 percent obstacle detection with the lowest rates of false alerts, under all weather and lighting conditions, including complete darkness, rain, haze, fog and glare. In contrast to other technologies, QuadSight is a passive sensor that does not emit any energy during operation. As a result, the QuadSight system does not create interference with other systems and is hazard-free.

The Eye-Net V2X System is a V2X (vehicle to everything) cellular-based accident prevention system designed to provide real-time pre-collision alerts to pedestrians and vehicles by using smartphones linked to existing cellular networks. The system is meant to identify an oncoming collision before the parties involved are able to see each other, and thus provide an alert that allows the parties to stop in a safe and timely manner. Put to the test in the Israeli city of Ashdod, Eye-Net met all of the pre-defined objectives and indicators for its real-time use in a manner that enabled all road users to brake safely and on time (http://ibn.fm/bi8lJ).

Demand for ADAS is expected to increase over the next decade, fueled largely by regulatory and consumer interest in safety applications that protect drivers and reduce accidents. Both the European Union and the United States are mandating that vehicles be equipped with autonomous emergency-braking systems and forward-collision warning systems by 2020, and car buyers are becoming even more interested in ADAS applications that promote comfort and economy, such as those that assist with parking or monitoring blind spots. As a result, the global market is projected to experience a CAGR of at least 16 percent over the next five years.

For more information, visit the company’s website at www.ForesightAuto.com

• Two separate market research reports predict 7.0 percent and 2.9 percent CAGR, respectively, in PreveCeutical’s areas of operation
• PreveCeutical developing Sol-Gel, an innovative medicine delivery platform

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is uniquely positioned to capitalize of the growth of two different markets in which it currently operates: dietary supplements and drug delivery systems. Two separate market research reports indicated recently that these sectors are expected to grow a projected 7.0 percent and 2.9 percent, respectively, over the next five years.

In a report published in May, Technavio estimated that the global dietary supplements market will post a compound annual growth rate (CAGR) of 7.0 percent between 2018 and 2022 (http://ibn.fm/WIDNW). Meanwhile, also in May, Mordor Intelligence predicted that the novel drug delivery systems market will have a CAGR of 2.9 percent over the same period (http://ibn.fm/9Nya2).

This is positive news for PreveCeutical, an innovator in preventative therapies and the developer of a unique medicine delivery platform based on cannabidiol (CBD), Sol-Gel, which will allow medicines to be applied through the nose and delivered directly to the brain.

Research has shown CBD to be non-psychoactive and to have anti-inflammatory, anti-anxiety and anti-emetic properties (http://ibn.fm/tO935). Following nasal administration, the formulations gel rapidly with mucosal tissue to facilitate direct nose-to-brain delivery of cannabinoids. The gel substantially improves bioavailability and provides controlled cannabinoid release, staying in the nasal passages for up to seven days.

PreveCeutical’s groundbreaking Sol-Gel delivery system displays significant benefits over other contemporary delivery systems. It bypasses first pass metabolism in the stomach, intestines and liver, exhibiting a dramatic improvement in bioavailability, even compared to nasal sprays and alternative delivery mechanisms. Unlike other delivery systems, PreveCeutical’s Sol-Gel delivery technology enables ease of application and provides long-lasting effects.

A number of delivery challenges often impact the effectiveness of medicines. Issues like high pill burdens and needle phobia can affect patient’s adherence to treatment. Some medical formulations contain harsh solvents which may lead to unwanted side effects, while other delivery modes pose challenges for patients with unique needs, such as children. Through the ease and simplicity of application, Sol-Gels address several of these challenges.

PreveCeutical is also developing solutions based on the peptides derived from Caribbean Blue Scorpion venom for pain management, cancer, cardiovascular conditions, metabolic disorders and infectious diseases.

For more information, visit the company’s website at www.PreveCeutical.com

• Sunniva confirms analyst expectations with COR from Health Canada
• Company and announcement featured in Seeking Alpha article
• Over one million square feet of cannabis cultivation facilities under construction
• Grow facilities in California and Canada target 60 million adults

Biopharmaceutical company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) now seems set for a place in the sun. The North American provider of cannabis products and services announced on May 29, 2018, that its wholly owned subsidiary, Sunniva Medical Inc. (“SMI”), had received a Confirmation of Readiness (COR) notification from Health Canada. The good news has not gone unnoticed, with one analyst remarking, “Sunniva Delivers As Promised,” as well as reminding investors that for Sunniva, “The Story Gets Better and Better.” Sunniva is positioned in the world’s two largest cannabis markets. The company currently has separate growing facilities under construction in the U.S., at its campus in Cathedral City, California, and in Canada at Okanagan Falls, British Columbia.

The COR received by Sunniva Medical Inc. (SMI) was issued under new rules instituted in May 2017 by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), which removed the necessity for a physical inspection of grow facilities prior to the issuance of a cultivation license. The new regime allows an applicant for a producer license to prove ‘their facility’s readiness in the form of data, photos, video, attestations from experts, etc.’, which, after review, can lead to the issue of a cultivation license. Designed to streamline the application process, the amended regulations do not remove the requirement for physical inspections entirely, but appear to place them on a scheduled timetable rather than before approval.

Although not quite a license to produce, a COR is a major step on the way to acquiring one. Sunniva certainly seems to have ‘everything lined up properly’, as a recent endorsement on Seeking Alpha testifies. Under the banner “Sunniva Delivers As Promised,” the review claims that the company might have issued its most important press release to date (http://ibn.fm/tBXUW).

The release, announcing receipt of the COR, also mentions other important company developments, such as the previously reported take or pay supply agreement with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (http://ibn.fm/S7I2R). Under the terms of the agreement, initially for two years, Canopy will purchase approximately 45 percent of Sunniva’s annual production capacity, representing 45,000 kilos of dried cannabis annually, starting in Q1 2019 or shortly thereafter. Canopy will also distribute Sunniva branded products.

Another item in the press release was the announcement that SMI had received development approval from the Regional District of Okanagan-Similkameen for construction of the Sunniva Canada Campus. SMI broke ground in early May 2018 on the 126-acre site at Okanagan Falls, British Columbia. Sunniva also revealed its plans to finance construction activities. It is currently arranging construction financing to finalize its planned state-of-the-art 740,000 square foot facility in Canada.

Work in California continues; under Phase 1 of the project there, a 325,000 square foot greenhouse with the capacity to produce 60,000 kilos of dry cannabis per year is expected to commence operations later this year. About half of that production will be used for conversion to oils and extracts. Phase 2 will increase greenhouse space by 165,000 square feet and increase annual output capacity by 40,000 kilos.

With construction at its campuses in California and Canada now well underway, Sunniva looks set to become a major supplier in this combined market of approximately 60 million adults, which is currently estimated at $9-10 billion.

For more information, visit the company’s website at www.sunniva.com

• xTHC produces cannabinoid-infused drink powders from a non-cannabis and non-hemp source using a patent-pending process
• Business model is to be a first-mover and expand into more U.S. states, with the focus now on the California market; goal is to reach broad-based retail channels, not only dispensaries
• Company is partnering with and is minority owner of Oregon-based Avitas CBD Water, LLC (now renamed Xanthic Beverages)

Xanthic Biopharma, Inc. (CSE: XTHC), on its initial investor conference call, projected multi-million dollar revenue and profitability in 2019 as it grows. It is a manufacturer of CBD-infused drink powder from a non-cannabis and non-hemp, economically viable and sustainable source. The company already has strategic partnerships in four U.S. states, with more locations in negotiations with manufacturers of bottled water and other beverages (http://ibn.fm/HYGpX).

xTHC, through wholly-owned subsidiary Xanthic Biopharma Ltd., provides its proprietary technology to industry participants, as well as branding and consulting services. Using a patent-pending process, it enables its partners to market CBD-infused drink powders that dissolve instantly in water and flavored beverages that deliver consistent and predictable dosing. The fine soluble powder is made from cannabis distillate.

xTHC is a Toronto-based first mover life sciences and technology cannabinoid company. It delivers cannabinoid dosing in preferred product formats. It is partnering with and invested in Xanthic Beverages and building its ‘Powered By Xanthic’ brand (http://ibn.fm/yBLIH). The company has a line of powder pouches to be mixed by the user in water.

Through private placements, the company raised about $3 million, capitalized the company for its RTO and began trading on the CSE. As of March 2018, xTHC had about $1.7 million in cash, fully funding its business plan.

Its business model is to distribute its products outside the cannabis dispensary network into broad-based retail channels, such as grocery and convenience stores. Xanthic Beverages will distribute Xanthic CBD Water to more than 500 retail locations in Washington and Oregon. Tim Moore, CEO of xTHC, says that the soluble powder “destigmatizes’ medical marijuana for patients and offers precise and consistent dosing (http://ibn.fm/XFrtx).

The company’s next focus is on distribution in California. xTHC has entered into a binding LOI with Nutritional High International, Inc. (CSE: EAT) (OTCQB: SPLIF) (http://ibn.fm/hBF4n). SPLIF operates a vertically integrated network that will manufacture and distribute Xanthic branded water in California.

For more information, visit the company’s website at www.XanthicBio.com

• Suite of events solutions cuts wait times for transactions through mobile services, quick verification
• Subsidiary PayOnline enters new market with Russian Federation offerings
• Multi-channel payments platform Netevia builds on same-day settlement in end-to-end processing

Mobile devices have become the go-anywhere remote controls that turn on — and turn off — the world around us. Net Element, Inc. (NASDAQ: NETE) is a fintech innovator that helps keep the signals open between businesses and their customers in a pay-per-play, on-demand-type marketplace that may be virtually headquartered anywhere between a business district, the highway or someone’s back yard.

Payment solutions provider Net Element has developed an expertise in linking mobile phones, brick and mortar stores, banks and unbanked web-based businesses to deliver reliable multi-channel possibilities to buyers and transaction analysis to the businesses who serve them. The company’s recent announcement that its subsidiary, Unified Payments, is launching an intelligent payment solution for the events industry (http://ibn.fm/vApjF) is an example of its efforts to provide the marketplace with future-ready options to serve vendors and the crowds to whom they cater.

Unified Payments’ suite of solutions makes it easier to eliminate lengthy wait times in line and keep service to the customer flowing “any time, any place, any payment” (http://ibn.fm/JFort) with self-order kiosks that provide charge-back protection. Value-added services provide help with quick account establishment, risk monitoring and advising for pricing models.

A report by the Events Industry Council notes that the meetings and events industry is pumping hundreds of billions of dollars into the U.S. economy, supporting 5.9 million jobs and continuing to expand, with an 18 percent increase in direct spending since 2012 (http://ibn.fm/R1MpZ).

In February, Net Element launched Netevia, a multi-channel payments platform that delivers end-to-end payment processing through easy-to-use APIs (http://ibn.fm/rAZ06). Its language-agnostic technology allows businesses to accept most payment methods in multiple currencies internationally. Same-business-day settlement and funding provides merchant security, while value-added features such as loyalty options help merchants build solutions to keep customers coming back.

Market analyst Statista projects that e-commerce retail worldwide will double its revenues to $4.88 trillion by 2021, stating in a report earlier this year that desktop PCs are still the world’s most popular device for placing shopping orders online but that mobile devices, especially smartphones, are catching up (http://ibn.fm/s3gVN).

Net Element subsidiary PayOnline began partnering with the Russian Federation’s Bank Sputnik last month to offer a comprehensive multi-channel solution to small and medium-sized businesses for their payment concerns, expanding PayOnline’s services beyond electronic commerce (http://ibn.fm/FwRHo). The company’s news release about the partnership notes that Statista Digital Markets predicts the total transaction value in the digital payments market segment in Russia will amount to $39.5 billion in 2018, up from $27.9 billion in 2016, and reach $61.8 billion by 2022 with a CAGR of 11.9 percent.

“This innovative, turnkey solution offers frictionless onboarding for merchants with integrated, value-added services,” Andrey Krotov, CTO of Net Element, stated in a news release. “With customizable payment flows, full-stack API and value-added solutions, PayOnline exceeds the unique needs of software platforms and merchants looking to enable payments in a multi-channel environment.”

For more information, visit the company’s website at www.NetElement.com

• ChineseInvestors.com enters licensing partnership with The Bad Crypto Podcast to redistribute popular interviews in the Chinese language
• Company announces partnership and recruiting efforts on MoneyTV
• Seen as latest step in a move to strengthen the company’s focus on being a leader in financial information

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company providing premier financial consulting to the Chinese-speaking community, recently announced that it has entered into a licensing partnership with The Bad Crypto Podcast. CIIX will be redistributing Chinese translations of the podcast’s most popular interviews on www.NewCoins168.com, which will include Charlie Lee, founder and developer of Litecoin; Roger Ver, also known as ‘Bitcoin Jesus’; and Patrick Bryne, Overstock.com CEO and founder of tZERO. CIIX CEO Warren Wang has also appeared on the show, first in December 2017 and again on May 23, 2018.

“Since it first aired in July 2017, The Bad Crypto Podcast hosted by Joel Comm, Bitcoin Evangelist and Travis Wright, Blockchain Entrepreneur, has become a worldwide phenomenon with over 150 episodes for curious individuals trying to figure out cryptocurrency, blockchain and the future of digital payments,” Wang stated in a news release. “We are confident that this lighthearted, entertaining programming offered in Chinese will be well received by viewers looking to expand their crypto knowledge whether they are newbies or more experienced crypto investors.”

This past week, CEO Warren Wang reported on company progress from New York City on MoneyTV with Donald Baillargeon (http://ibn.fm/GABMq). Wang shared news regarding the partnership with The Bad Crypto Podcast. Wang also shared that he was in New York recruiting more key players for this new project.

CIIX is the leading financial information website for Chinese-speaking investors, reaching a global audience. Using traditional and simplified Chinese character sets, this fintech company provides online financial information to the Chinese-speaking community. With online editorial reporters in New York, Los Angeles and China, the company is able to provide 24/7 coverage of the industry. The addition of The Bad Crypto Podcast is one more step in a move to strengthen the company’s focus on being a leader in financial information. This podcast will join the ever-growing educational services provided by CIIX. The company has been providing educational offerings on the crypto news website www.NewCoins168.com, through the Bitcoin MultiMillionaire daily video broadcast and from the floor cryptocurrency news reporting at the New York Stock Exchange.

For more information, visit the company’s website at www.ChineseInvestors.com